T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Kennametal
KMT
$2.38B
| $1.39M | ﹤0.01% |
34,798
-677,401
| -95% | -$26.4M |
|
1877
Oceaneering
OII
$5.24B
| $1.39M | ﹤0.01% |
121,772
+27,442
| +29% | +$304K |
|
1878
Community Bank
CBU
$3.45B
| $1.39M | ﹤0.01% |
18,097
+1,799
| +11% | +$129K |
|
|
VRE
1879
DELISTED
Veris Residential
VRE
| $1.38M | ﹤0.01% |
89,316
+3,251
| +4% | +$45.9K |
|
|
TBCH
1880
Turtle Beach Corp
TBCH
$225M
| $1.38M | ﹤0.01% |
51,865
+4,496
| +9% | +$123K |
|
1881
Independence Realty Trust
IRT
$4.02B
| $1.38M | ﹤0.01% |
90,801
-7,481
| -8% | -$106K |
|
1882
Piper Sandler
PIPR
$5.46B
| $1.38M | ﹤0.01% |
50,208
+108
| +0.2% | +$2.86K |
|
1883
Adeia
ADEA
$3.3B
| $1.38M | ﹤0.01% |
238,809
+11,468
| +5% | +$66.1K |
|
1884
Four Corners Property Trust
FCPT
$2.76B
| $1.37M | ﹤0.01% |
50,142
+97
| +0.2% | +$2.67K |
|
|
WCC
1885
WESCO International
WCC
$17.6B
| $1.37M | ﹤0.01% |
15,875
+4,738
| +43% | +$399K |
|
|
CLDT
1886
Chatham Lodging
CLDT
$601M
| $1.37M | ﹤0.01% |
104,220
-5,206
| -5% | -$66.2K |
|
|
RPT
1887
Rithm Property Trust
RPT
$104M
| $1.37M | ﹤0.01% |
+20,978
| New | +$1.39M |
|
1888
Greif
GEF
$4.99B
| $1.37M | ﹤0.01% |
24,005
-1,209
| -5% | -$62.2K |
|
|
ITCI
1889
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.37M | ﹤0.01% |
40,289
+8,799
| +28% | +$305K |
|
1890
Inovio Pharmaceuticals
INO
$106M
| $1.35M | ﹤0.01% |
12,151
-931
| -7% | -$122K |
|
1891
Skywest
SKYW
$4.15B
| $1.35M | ﹤0.01% |
24,829
+6,574
| +36% | +$324K |
|
1892
Xerox
XRX
$408M
| $1.35M | ﹤0.01% |
55,764
-229,394
| -80% | -$5.48M |
|
1893
Artisan Partners
APAM
$3.01B
| $1.35M | ﹤0.01% |
25,903
+3,122
| +14% | +$159K |
|
1894
Northwest Natural Holdings
NWN
$2.13B
| $1.35M | ﹤0.01% |
25,020
+974
| +4% | +$46.7K |
|
|
UMPQ
1895
DELISTED
Umpqua Holdings Corp
UMPQ
| $1.34M | ﹤0.01% |
76,529
+13,597
| +22% | +$230K |
|
1896
Editas Medicine
EDIT
$428M
| $1.34M | ﹤0.01% |
31,961
+5,023
| +19% | +$286K |
|
1897
Shenandoah Telecom
SHEN
$738M
| $1.34M | ﹤0.01% |
27,445
-7
| -0% | -$320 |
|
|
NSTG
1898
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.34M | ﹤0.01% |
20,378
+3,099
| +18% | +$218K |
|
1899
Sanmina
SANM
$11.2B
| $1.34M | ﹤0.01% |
32,277
+1,301
| +4% | +$47.3K |
|
1900
Wolverine World Wide
WWW
$1.71B
| $1.34M | ﹤0.01% |
34,858
-10,465
| -23% | -$361K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.